相关实验视频

Updated: Jul 1, 2025

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

开发一个度目标干预措施,以个性化对囊性夜间血红蛋白尿症进行治疗,使用佩克西塔科普兰

Mendy Ter Avest¹, Saskia M C Langemeijer², Nicole M A Blijlevens²

¹Department of Pharmacy, Radboud University Medical Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands. mendy.teravest@radboudumc.nl.

Annals of hematology

|March 7, 2024

概括

在阳性夜间血红蛋白尿症中,对佩格塞塔科普兰 (Aspaveli®/EmpaveliTM) 的个性化剂量可以改善大约30%的患者的患者方便性. 这种方法也可以提高治疗的小百分比,同时可能降低成本.

科学领域:

药理学药理学是指药理学的学科.
血液学血液学血液学
临床试验模拟的临床试验

背景情况:

佩格塞塔科普兰是一种C3抑制剂,已被批准用于 Paroxysmal 夜间血红蛋白尿症 (PNH).
目前的剂量可能不是最佳的患者友好或成本效益.
个性化剂量可以提高治疗结果和资源利用率.

研究的目的:

开发一个个性化的佩格塞塔科普兰剂量方案.
用药理动力学-药理动力学 (PK-PD) 数据来优化治疗方案.
为了比较PNH患者的个性化剂量与已批准的治疗方案.

主要方法:

临床试验模拟比较批准与目标度基于干预的剂量.
包括之前接受过或没有接受过eculizumab治疗的患者.
评估乳酸脱酶 (LDH) 和血红蛋白正常化作为疗效终点.

主要成果:

个性化剂量实现了与批准方案相比,可比的LDH和血红蛋白正常化率.
通过个性化方法,可以适度降低剂量 (~5%).
剂量间隔调整是可能的,28.2%的患者从长时间间隔中受益.

结论:

一个个性化的剂量策略 pegcetacoplan 显示了改善患者友好性的潜力.
这种方法可能会增强小患者子组的治疗.
个性化剂量可以带来轻微的成本降低和改善PNH的治疗个性化.

关键词:

补充补充补充补充帕洛克斯夜性血红素尿.在Pegcetacoplan上使用Pegceta.药理动力学是什么药理动力学药理动力学药理动力学

更多相关视频

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...